News

Check out market updates

Boulder-based oncology company Enliven Therapeutics raises $55M Series A

BOULDER — Enliven Therapeutics Inc., a Boulder-based cancer-drug developer, is exiting from stealth operations by announcing that it raised $55 […]
Source: BizWest

Leave a Reply

Your email address will not be published. Required fields are marked *

X